Highlights in Genitourinary Cancer

Erdafitinib Improves Overall Survival vs Chemotherapy in FGFR-Altered Advanced Urothelial Carcinoma  Erdafitinib (Balversa, Janssen) significantly improves overall survival (OS) compared with chemotherapy in patients with FGFR-altered […]